Nijmegen, Netherlands Wednesday, April 23, 2025, 13:00 Hrs [IST] ...

Recursion will present preliminary data during the 2025 Digestive Disease Week meeting from its ongoing Phase 1b/2 ...

Following a recent Type D meeting with the FDA, a phase 3 clinical trial design for darovasertib in primary uveal melanoma ...

Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseasesHOUSTON, April 22, ...

Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...

Brainstorm Cell Therapeutics is seeking FDA clearances to launch a Phase 3b clinical trial to test its NurOwn stem cell ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...